rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Keith J. Sullivan

Other role

Company insider

Files Form 4 as: President and CEO, Neuronetics; Director, Cutera; Director, Venus Concept; Interim GM miraDry, Sientra; CCO, President, North America, Zeltiq Aesthetics.

In numbers

Trades disclosed
193
Buys
4
Sells
59
Bought
$390K
Sold
$8.6M
Companies
5
Companies where not an officer
2
First trade
4 Oct 2012
Last trade
19 Mar 2026
Last filed
24 Mar 2026

Companies traded

Where they are an officer
STIM NeuroneticsDirector, Officer, Other · Medical Devices · last 19 Mar 20260 buys · 26 sells
SientraDirector, Officer · last 9 Jun 20222 buys · 0 sells
Zeltiq AestheticsOfficer · last 4 Jan 20171 buy · 29 sells
Everywhere else they filed: board seats, 10% stakes, other companies
CuteraDirector · last 24 Oct 20240 buys · 0 sells
Venus ConceptDirector · last 24 Mar 20231 buy · 4 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
30Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
19 Mar 2026filed 24 Mar 2026STIM NeuroneticsMedical DevicesSEC FORM 4 Sold$62K46,289 at $1.34filing
19 Mar 2026filed 24 Mar 2026STIM NeuroneticsMedical DevicesSEC FORM 4 Sold$62K46,289 at $1.34filing
17 Mar 2026filed 18 Mar 2026STIM NeuroneticsMedical DevicesSEC FORM 4 Code A—112,500 at $0.00filing
17 Mar 2026filed 18 Mar 2026STIM NeuroneticsMedical DevicesSEC FORM 4 Code A—112,500 at $0.00filing
26 Feb 2026filed 27 Feb 2026STIM NeuroneticsMedical DevicesSEC FORM 4 Sold$11K8,452 at $1.35filing
26 Feb 2026filed 27 Feb 2026STIM NeuroneticsMedical DevicesSEC FORM 4 Sold$11K8,452 at $1.35filing
12 Feb 2026filed 18 Feb 2026STIM NeuroneticsMedical DevicesSEC FORM 4 Sold$56K33,847 at $1.65filing
12 Feb 2026filed 18 Feb 2026STIM NeuroneticsMedical DevicesSEC FORM 4 Sold$56K33,847 at $1.65filing
10 Feb 2026filed 12 Feb 2026STIM NeuroneticsMedical DevicesSEC FORM 4 Sold$64K40,976 at $1.55filing
10 Feb 2026filed 12 Feb 2026STIM NeuroneticsMedical DevicesSEC FORM 4 Sold$64K40,976 at $1.55filing
24 Feb 2025filed 13 Mar 2025STIM Neuroneticsoption or derivative · Medical DevicesSEC FORM 4 Code A—187,500 at $0.00filing
24 Feb 2025filed 26 Feb 2025STIM Neuroneticsoption or derivative · Medical DevicesSEC FORM 4 Code A—187,500 at $0.00filing
24 Feb 2025filed 26 Feb 2025STIM NeuroneticsMedical DevicesSEC FORM 4 Code A—375,000 at $0.00filing
19 Feb 2025filed 20 Feb 2025STIM NeuroneticsMedical DevicesSEC FORM 4 Sold$115K24,440 at $4.70filing
18 Feb 2025filed 20 Feb 2025STIM NeuroneticsMedical DevicesSEC FORM 4 Sold$114K25,934 at $4.41filing
10 Feb 2025filed 12 Feb 2025STIM NeuroneticsMedical DevicesSEC FORM 4 Sold$134K40,992 at $3.28filing
10 Dec 2024filed 12 Dec 2024STIM Neuroneticsoption or derivative · Medical DevicesSEC FORM 4 Code A—450,000 at $0.00filing
24 Oct 2024filed 5 Nov 2024Cuteraoption or derivativeSEC FORM 4 Code A—20,000 at $0.00filing
18 Jul 2024filed 22 Jul 2024STIM NeuroneticsMedical DevicesSEC FORM 4 Sold$46K24,162 at $1.90filing
17 Jul 2024filed 18 Jul 2024STIM NeuroneticsMedical DevicesSEC FORM 4 Sold$23K11,687 at $1.97filing

News

Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference CallSTIM · manilatimes.net · 21 Oct 2026

0 headlines in the last 90 days name Keith J. Sullivan; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care26
Not placed37

Buys in green, sells in red, by the company’s sector.

Related people

Jorey Chernett10% owner · 10% owner at Neuronetics, filing Form 4 there in the last year
Nir NaorEVP, CFO & Treasurer · EVP, CFO & Treasurer at Neuronetics, filing Form 4 there in the last year
Madryn Asset Management, LP10% owner · 10% owner at Neuronetics, filing Form 4 there in the last year
Avinash AminDirector · Director at Neuronetics, filing Form 4 there in the last year
Megan RosengartenDirector · Director at Neuronetics, filing Form 4 there in the last year